These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25450431)

  • 1. Effects of presenting risk information in different formats to cardiologists. A Latin American survey.
    Borracci RA; Piñeiro DJ; Arribalzaga EB
    Arch Cardiol Mex; 2015; 85(1):3-8. PubMed ID: 25450431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized comparison of patients' understanding of number needed to treat and other common risk reduction formats.
    Sheridan SL; Pignone MP; Lewis CL
    J Gen Intern Med; 2003 Nov; 18(11):884-92. PubMed ID: 14687273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in cardiology professionals: A Latin American Survey.
    Raymundo-Martínez GIM; Alanis-Estrada GP; Araiza-Garaygordobil D; Delgado-Cruz IV; Gopar-Nieto R; Cabello-López A; Martínez-Amezcua P; Arias-Mendoza MA
    Arch Cardiol Mex; 2022; 92(1):11-18. PubMed ID: 34987234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The number needed to treat (NNT) and the number needed to harm (NNH)].
    Suter K; Briel M; Günther J
    Med Monatsschr Pharm; 2015 Mar; 38(3):103-6. PubMed ID: 26364396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The number needed to treat as a measure of effect in the treatment of primary immune thrombocytopenia].
    Vizcaíno G; Vizcaíno-Carruyo J
    Invest Clin; 2012 Mar; 53(1):16-27. PubMed ID: 22524105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The number needed to treat (NNT)].
    Richard T; Vanhaeverbeek M; Van Meerhaeghe A
    Rev Med Brux; 2011; 32(5):453-8. PubMed ID: 22165523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The production of articles on cardiology from Latin America in Medline indexed journals.
    Borracci RA; Di Stéfano MM; Voos Budal Arins MG; Calderón JG; Manente D; Giorgi MA; Piñeiro DJ; Dones W
    Arch Cardiol Mex; 2011; 81(4):343-50. PubMed ID: 22188892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Joint and separate evaluation of risk reduction: impact on sensitivity to risk reduction magnitude in the context of 4 different risk information formats.
    Gyrd-Hansen D; Halvorsen P; Nexøe J; Nielsen J; Støvring H; Kristiansen I
    Med Decis Making; 2011; 31(1):E1-10. PubMed ID: 21173438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Communicating Absolute Fracture Risk Reduction and the Acceptance of Treatment for Osteoporosis.
    Ralston KAP; Phillips J; Krause A; Hauser B; Ralston SH
    Calcif Tissue Int; 2022 Jun; 110(6):698-702. PubMed ID: 35152304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of presenting absolute v. relative risk reduction in the elicitation of patient values for heart disease prevention with conjoint analysis.
    Griffith JM; Lewis CL; Hawley S; Sheridan SL; Pignone MP
    Med Decis Making; 2009; 29(2):167-74. PubMed ID: 19279298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in clinical decision making between internists and cardiologists.
    Glassman PA; Kravitz RL; Petersen LP; Rolph JE
    Arch Intern Med; 1997 Mar; 157(5):506-12. PubMed ID: 9066454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' and cardiologists' perceptions of the benefits of percutaneous coronary intervention for stable coronary disease.
    Rothberg MB; Sivalingam SK; Ashraf J; Visintainer P; Joelson J; Kleppel R; Vallurupalli N; Schweiger MJ
    Ann Intern Med; 2010 Sep; 153(5):307-13. PubMed ID: 20820040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient and cardiologist perceptions on decision making for implantable cardioverter-defibrillators: a qualitative study.
    Matlock DD; Nowels CT; Masoudi FA; Sauer WH; Bekelman DB; Main DS; Kutner JS
    Pacing Clin Electrophysiol; 2011 Dec; 34(12):1634-44. PubMed ID: 21972983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of the presentation of results from clinical trials on the intention to prescribing: relativity of the relative risk].
    Meneu Ricardo R; Peiró S; Márquez Calderón S
    Aten Primaria; 1998 Apr; 21(7):446-50. PubMed ID: 9656582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative risk, absolute risk and number needed to treat: basic concepts.
    Carneiro AV
    Rev Port Cardiol; 2009 Jan; 28(1):83-7. PubMed ID: 19388495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absolute risk reduction in total mortality with implantable cardioverter defibrillators: analysis of primary and secondary prevention trial data to aid risk/benefit analysis.
    Betts TR; Sadarmin PP; Tomlinson DR; Rajappan K; Wong KC; de Bono JP; Bashir Y
    Europace; 2013 Jun; 15(6):813-9. PubMed ID: 23365069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do drug treatment POEMs report data in clinically useful ways?
    Duncan B; Ables AZ
    J Fam Pract; 2013 Feb; 62(2):E1-5. PubMed ID: 23405382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiologists' use of percutaneous coronary interventions for stable coronary artery disease.
    Lin GA; Dudley RA; Redberg RF
    Arch Intern Med; 2007 Aug 13-27; 167(15):1604-9. PubMed ID: 17698682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presenting risk information to people with diabetes: evaluating effects and preferences for different formats by a web-based randomised controlled trial.
    Edwards A; Thomas R; Williams R; Ellner AL; Brown P; Elwyn G
    Patient Educ Couns; 2006 Nov; 63(3):336-49. PubMed ID: 16860964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary risk estimates and decisions on lipid-lowering treatment in primary prevention: comparison between general practitioners, internists, and cardiologists.
    Vancheri F; Strender LE; Montgomery H; Skånér Y; Backlund LG
    Eur J Intern Med; 2009 Oct; 20(6):601-6. PubMed ID: 19782921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.